Hepatic Encephalopathy – Causes and Treatment
Hepatic encephalopathy is a brain dysfunction caused by severe liver disease. It leads to confusion, impaired consciousness, and neurological deficits due to the buildup of toxic substances in the blood.
Wissenswertes über "Hepatic Encephalopathy"
Hepatic encephalopathy is a brain dysfunction caused by severe liver disease. It leads to confusion, impaired consciousness, and neurological deficits due to the buildup of toxic substances in the blood.
What is Hepatic Encephalopathy?
Hepatic encephalopathy (HE) is a serious complication of liver disease in which brain function becomes impaired. It occurs when the liver can no longer adequately remove toxic metabolic byproducts – most notably ammonia – from the bloodstream. These substances cross the blood-brain barrier and disrupt normal neurological function. Hepatic encephalopathy most commonly affects patients with liver cirrhosis, acute liver failure, or portosystemic shunts.
Causes
The primary cause of hepatic encephalopathy is impaired liver detoxification function. Key underlying conditions and triggering factors include:
- Liver cirrhosis: The most common predisposing condition, in which healthy liver tissue is replaced by scar tissue
- Acute liver failure: Sudden and severe loss of liver function, e.g., due to drug toxicity or viral hepatitis
- Portosystemic shunts: Collateral blood vessels that bypass the liver, allowing toxins to enter the systemic circulation unfiltered
- Precipitating factors: Infections, gastrointestinal bleeding, constipation, certain medications (e.g., sedatives), excessive protein intake, or electrolyte imbalances
Symptoms
The symptoms of hepatic encephalopathy range from subtle cognitive changes to deep coma. The condition is graded using the West Haven Criteria:
- Grade I: Mild confusion, mood changes, sleep disturbances, reduced attention span
- Grade II: Disorientation, lethargy, abnormal behavior, asterixis (flapping tremor of the hands)
- Grade III: Marked confusion, somnolence, barely responsive, incoherent speech
- Grade IV: Deep coma, no response to painful stimuli
A characteristic fetor hepaticus – a sweet, musty odor on the breath – may also be present, caused by volatile metabolic byproducts of impaired liver metabolism.
Diagnosis
Diagnosis is based on a combination of clinical assessment, laboratory findings, and imaging:
- Clinical evaluation: Assessment of consciousness and neurological symptoms using the West Haven Criteria
- Laboratory tests: Elevated blood ammonia levels, liver function parameters (bilirubin, ALT, AST, INR/prothrombin time), full blood count, electrolytes
- Psychometric testing: To detect minimal or covert hepatic encephalopathy (e.g., Number Connection Test)
- EEG: Detection of characteristic slow-wave activity (theta and delta waves)
- Imaging: MRI or CT of the brain to exclude other causes such as stroke or intracranial bleeding
Treatment
Treatment of hepatic encephalopathy focuses on eliminating precipitating factors, lowering ammonia levels, and supporting brain function.
General Measures
- Identification and treatment of triggering factors (e.g., treating infections, managing gastrointestinal bleeding)
- Medication review and adjustment (e.g., discontinuing sedatives or diuretics)
- Adequate caloric intake with appropriate protein supply – a blanket protein restriction is no longer recommended
Pharmacological Therapy
- Lactulose: A non-absorbable disaccharide that accelerates intestinal transit and reduces gut ammonia production – considered first-line treatment
- Rifaximin: A minimally absorbed antibiotic that suppresses ammonia-producing gut bacteria; primarily used for secondary prevention of episodes
- Zinc supplementation: Zinc is involved in the urea cycle and ammonia detoxification; deficiency is common in liver cirrhosis
- L-ornithine L-aspartate (LOLA): Supports ammonia detoxification via the urea cycle and glutamine synthesis
Causal Treatment
In advanced liver disease, liver transplantation may be the only curative option. It addresses the underlying disease and typically leads to significant improvement or complete resolution of hepatic encephalopathy.
Prognosis and Course
The prognosis depends heavily on the severity of the underlying liver disease and the grade of encephalopathy. Episodic hepatic encephalopathy triggered by a clearly identifiable cause is often reversible and manageable with appropriate treatment. Persistent or recurrent hepatic encephalopathy, however, indicates severe hepatic dysfunction and is associated with a significantly poorer prognosis. Without treatment, acute liver failure with severe hepatic encephalopathy can be life-threatening.
References
- European Association for the Study of the Liver (EASL): Clinical Practice Guidelines on the Management of Hepatic Encephalopathy. Journal of Hepatology, 2022.
- Vilstrup H. et al.: Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 2014.
- Ferenci P. et al.: Hepatic Encephalopathy – Definition, Nomenclature, Diagnosis, and Quantification. Hepatology, 2002.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryVital Nutrient Biokinetics
Pancreatic Parenchyma
Growth Factor Secretion
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Cologne list
Calorie content
Related search terms: Hepatic Encephalopathy + Hepatic Encephalopathy + Portosystemic Encephalopathy